Compare EHTH & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EHTH | CDXS |
|---|---|---|
| Founded | 1997 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.1M | 141.8M |
| IPO Year | 2006 | 2010 |
| Metric | EHTH | CDXS |
|---|---|---|
| Price | $3.48 | $1.76 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 296.6K | ★ 763.5K |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $542,951,000.00 | $52,932,000.00 |
| Revenue This Year | $4.61 | $15.64 |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | $78.88 | ★ N/A |
| Revenue Growth | ★ 16.79 | N/A |
| 52 Week Low | $3.18 | $1.52 |
| 52 Week High | $11.36 | $5.16 |
| Indicator | EHTH | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 36.39 | 53.31 |
| Support Level | $3.43 | $1.61 |
| Resistance Level | $3.67 | $1.74 |
| Average True Range (ATR) | 0.20 | 0.09 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 4.35 | 57.14 |
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.